NCT01087281

Brief Summary

Background: \- Previous studies have shown that people with certain types of brain damage may have particular problems paying attention and processing things that they see. Researchers are interested in comparing how people with brain damage and without brain damage process visual images. Objectives: \- To better understand the areas of the brain involved in paying attention to things that are seen. Eligibility: \- Individuals at least 18 years of age who either have had damage to one or both sides of specific parts of the brain (e.g., stroke, injury, certain neurosurgery procedures) or are healthy volunteers. Design:

  • The study involves 4 to 10 visits to the NIH Clinical Center over 1 to 2 years. Each visit will last approximately 2 hours.
  • Participants will be screened with a medical history and physical examination, and may have the cognitive testing described below during the same visit.
  • On the first visit and for at least one visit thereafter, participants will have cognitive testing to evaluate thinking and memory. These tests will be either written tests or computer-based tests.
  • Some participants will qualify for functional magnetic resonance imaging (fMRI) as part of the study. This part will involve a decision-making task that will be performed on a computer during the fMRI scan. Additional scans may be required as directed by the study doctors.
  • Some randomly selected participants will be asked to have magnetoencephalography (MEG), a procedure to record very small magnetic field changes produced by brain activity.
  • During the behavioral training, or fMRI or MEG scanning, participants may be monitored with equipment to track eye movements.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 13, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 16, 2010

Completed
2.4 years until next milestone

Study Start

First participant enrolled

July 23, 2012

Completed
Last Updated

June 12, 2026

Status Verified

May 28, 2026

First QC Date

March 13, 2010

Last Update Submit

June 11, 2026

Conditions

Keywords

Visual AttentionVisual CortexFocal LesionsNeurological DisorderFunctional Magnetic Resonance Imaging (fMRI)Natural HistoryFocal Brain LesionHealthy VolunteerHV

Outcome Measures

Primary Outcomes (1)

  • MRI signal across the whole brain during the MRI scans

    The MRI signal varies with cortical area and with the stimuli and tasks performed by the subjects.

    Ongoing

Study Arms (2)

1

Neurologically normal healthy volunteers in good general health.

2

Patients with unilateral or bilateral focal lesions of prefrontal, parietal, occipital or temporal cortex, or amygdala.

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy volunteers 18 years of age or older who are neurologically normal and in good general health. Patients 18 years of age or older with unilateral or bilateral focal lesions of prefrontal, parietal, occipital or temporal cortex, or amygdala.

You may qualify if:

  • All Subjects
  • All subjects will be 18 years of age or older and have at least a high school education.
  • Capacity to provide their own informed consent, understand and cooperate with study procedures.
  • Able to read and write in English to guarantee understanding of all written and spoken instructions, which are in English.
  • Patients:
  • Unilateral or bilateral focal lesions of prefrontal, parietal, occipital or temporal cortex, or amygdala.
  • At least three months post-stroke, lobectomy and or neurosurgical resection.
  • Healthy volunteers:
  • \. Neurologically normal and in good general health.

You may not qualify if:

  • Patients:
  • Any neurological or psychiatric disorder not related to the focal lesion (e.g., epilepsy, schizophrenia, etc.). Epilepsy patients who have undergone surgery and as a result are seizure free may be recruited.
  • Previous head injury.
  • Present or past (within past 6 months) drug or alcohol abuse or addiction as determined by a qualified study neurologist/psychiatrist.
  • Radiation treatment to the brain during a three-month period prior to the experiment.
  • Healthy volunteers:
  • Any neurological or psychiatric disorder (e.g., epilepsy, schizophrenia, etc.)
  • Previous head injury.
  • Present or past (within past 6 months) drug or alcohol abuse or addiction based on DSM-5 criteria as determined during History and Physical exam.
  • Patients and Healthy volunteers:
  • Women who are pregnant and women of child-bearing potential who refuse to undergo a urine pregnancy test will be excluded from fMRI experiments.
  • Subjects who have contraindications to MRI scanning will be excluded from fMRI experiments but included in cognitive experiments. These contraindications include:
  • central nervous system aneurysm clips;
  • implanted neural stimulator;
  • implanted cardiac pacemaker or defibrillator;
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

RECRUITING

Related Publications (6)

  • Bandettini PA, Wong EC, Hinks RS, Tikofsky RS, Hyde JS. Time course EPI of human brain function during task activation. Magn Reson Med. 1992 Jun;25(2):390-7. doi: 10.1002/mrm.1910250220.

    PMID: 1614324BACKGROUND
  • Belliveau JW, Kennedy DN Jr, McKinstry RC, Buchbinder BR, Weisskoff RM, Cohen MS, Vevea JM, Brady TJ, Rosen BR. Functional mapping of the human visual cortex by magnetic resonance imaging. Science. 1991 Nov 1;254(5032):716-9. doi: 10.1126/science.1948051.

    PMID: 1948051BACKGROUND
  • Fox PT, Raichle ME, Mintun MA, Dence C. Nonoxidative glucose consumption during focal physiologic neural activity. Science. 1988 Jul 22;241(4864):462-4. doi: 10.1126/science.3260686.

    PMID: 3260686BACKGROUND
  • Gilmore AW, Audrain S, Snow J, Gollomp E, Wilson JM, Agron AM, Hammoud DA, Butman JA, Martin A. Long-term retention of real-world experiences in a patient with profound amnesia. Neuropsychologia. 2024 Nov 5;204:109010. doi: 10.1016/j.neuropsychologia.2024.109010. Epub 2024 Oct 9.

  • Zhang H, Japee S, Nolan R, Chu C, Liu N, Ungerleider LG. Face-selective regions differ in their ability to classify facial expressions. Neuroimage. 2016 Apr 15;130:77-90. doi: 10.1016/j.neuroimage.2016.01.045. Epub 2016 Jan 28.

  • Hansen KA, Chu C, Dickinson A, Pye B, Weller JP, Ungerleider LG. Spatial selectivity in the temporoparietal junction, inferior frontal sulcus, and inferior parietal lobule. J Vis. 2015;15(13):15. doi: 10.1167/15.13.15.

Related Links

MeSH Terms

Conditions

Nervous System Diseases

Study Officials

  • Shruti A Japee, Ph.D.

    National Institute of Mental Health (NIMH)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Shruti A Japee, Ph.D.

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 13, 2010

First Posted

March 16, 2010

Study Start

July 23, 2012

Last Updated

June 12, 2026

Record last verified: 2026-05-28

Locations